Swiss Doctors Approved to Use Kerecis Omega3 Wound Fish Skin Starting this March
Kerecis, the creator, manufacturer and patent holder of fish-skin therapeutic products, is making great strides in Switzerland. The company announced on Thursday that they received notice from Swiss healthcare authorities that their lead product, Kerecis Omega3 Wound, will be reimbursed in Switzerland. In addition, the company will acquire Swiss life-science company Phytoceuticals, a move that Kerecis hopes will strengthen their position in Europe in the field of regenerative treatment of tissue and organ damage.
Kerecis Omega3 Wound is a tissue-based, skin-substitute product that...
To Read Full Story Login Below.